Fundz

Biostage, Inc. reported raising $5.06 Million in an initial SEC Form D filing, from an offering of $5.06 Million

PUBLIC · HRGNJun 08, 2022

Amount Raised

$5.06 Million

$5.06 Million sold, per SEC Form D (first sale Jun 8, 2022)

Round Type

Venture

HollistonManufacturingBiotechnologyHealth CareMedical Device

Who to call at Harvard Apparatus Regenerative Technology, and when

A new round usually means Harvard Apparatus Regenerative Technology is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Harvard Apparatus Regenerative Technology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Harvard Apparatus Regenerative Technology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Harvard Apparatus Regenerative Technology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Harvard Apparatus Regenerative Technology

Location

Holliston, Massachusetts, United States

About

Biostage, Inc. (OTCQB: formerly BSTG) changed its corporate name back to Harvard Apparatus Regenerative Technology, Inc. and began trading under the OTCQB symbol "HRGN" effective July 20, 2023. Harvard Apparatus Regenerative Technology, Inc., is a clinical stage biotechnology company that is focused on the development of organ replacement therapies using cellular scaffolds and tissue engineering to restore organ function.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Harvard Apparatus Regenerative Technology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

4 contacts
Verified contactsWilliam F., Chief Scientific Officer hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Harvard Apparatus Regenerative Technology's next move

See what Strategic adds

Harvard Apparatus Regenerative Technology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.